Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
44 records found for “NCT07047612” · show all
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoShiyan People's Hospital, Shiyan, Hubei, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoXiangya Hospital of Central South University, Changsha, Hunan, 410008, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First People's Hospital of Lianyungang, Lianyungang, Jiangsu, 222061, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoSuzhou Municipal Hospital, Suzhou, Jiangsu, 215002, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoDermatology hospital of jiangxi province, Nanchang, Jiangxi, 330000, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe first hospital of Jilin Univercity, Changchun, Jilin, 130021, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoZibo Central Hospital, Zibo, Shandong, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoHuashan Hospital Fudan University, Shanghai, Shanghai Municipality, 200040, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoShanghai Dermatology Hospital, Shanghai, Shanghai Municipality, 200050, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoChengdu Second People's Hospital, Chengdu, Sichuan, 610021, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital Of Kunming Medical University, Kunming, Yunnan, 650032, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoHangzhou Third People's Hospital, Hangzhou, Zhejiang, 310009, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital Of Ningbo University, Ningbo, Zhejiang, 315100, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe Fourth Affiliated Hospital, Zhejiang University School Of Medicine, Yiwu, Zhejiang, 322000, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of Fujian Medical, Fuzhou, Fujian, 350005, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoNanfang Hospital, Guangzhou, Guangdong, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of University Of South China, Hengyang, Hunan, China
021-52887775
FAQOther Questions
- Safety of clinical trials. Can my child leave it for any reason?
Pediatric vitiligo trials · Safety and choice Who watches your child, what may need to pause and what happens if your family changes its mind. Two studies discussed here are eva...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
- Vitiligo trials for kids: basics for the parents
Pediatric vitiligo trials · The basics Two parallel studies are evaluating investigational use of ruxolitinib cream in young children — researchers are still finding out how wel...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.